Drug Substitution Questions: Januvia®, Zituvio® and sitagliptin
PAAS National® analysts are receiving numerous inquiries regarding the substitution of Januvia®, Zituvio® and sitagliptin. The sitagliptin product made by Zydus Pharmaceuticals is identified as …
an Authorized Generic of Zituvio® and may be substituted at the pharmacy level without prescriber approval. Please note that pharmacies may not substitute sitagliptin for Januvia®, nor can they substitute Zituvio® for Januvia® unless the prescriber approves, and this is documented with a clinical note.
Here is an excerpt from the FDA website explaining Authorized Generics:
“An authorized generic drug is the same as the brand-name drug but does not use the brand name on the label. In addition, an authorized generic version of a tablet or capsule may have a different color or marking. Because an authorized generic drug is marketed under the brand name drug’s New Drug Application (NDA), it is not listed in FDA’s Approved Drug Products With Therapeutic Equivalence Evaluations (the Orange Book). An authorized generic is considered to be therapeutically equivalent to its brand-name drug because it is the same drug.”
Here is a comparison table to help pharmacies understand the differences, note the matching FDA application numbers of Zituvio® and sitagliptin.
Product | Strengths Available | NDC | Manufacturer | FDA Application Number | Marketing Category |
Januvia® | 25 mg 50 mg 100 mg | 00006-0221-xx 00006-0112-xx 00006-0277-xx | Merck Sharp & Dohme LLC | 021995 | NDA |
Zituvio® | 25 mg 50 mg 100 mg | 70710-1240-03 70710-1241-03 70710-1242-03 | Zydus Pharmaceuticals | 211566 | NDA |
Sitagliptin | 25 mg 50 mg 100 mg | 70710-1899-xx 70710-1900-xx 70710-1901-xx | Zydus Pharmaceuticals | 211566 | NDA Authorized Generic |
NDCs with “xx” have multiple pack sizes
PAAS Tips:
- Authorized generics are NOT separately listed in FDA Orange Book
- If you are ever in doubt about product substitution, call the PAAS team for assistance
- What FWA and HIPAA Compliance Elements are Necessary for Interns, Job Shadows, Floating Staff, Cashiers and Delivery Drivers? - September 15, 2024
- Drug Substitution Questions: Januvia®, Zituvio® and sitagliptin - September 9, 2024
- The Double Threat: Ransomware Attack Followed by HIPAA Non-Compliance Settlement - August 30, 2024